Copyright Reports & Markets. All rights reserved.

Global Influenza Vaccines Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Influenza Vaccines Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Influenza Vaccines Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Influenza Vaccines Market Size Growth Rate by Type
    • 1.4.2 Trivalent Flu Vaccines
    • 1.4.3 Quadrivalent Flu Vaccines
  • 1.5 Market by Application
    • 1.5.1 Global Influenza Vaccines Market Size Growth Rate by Application
    • 1.5.2 Adults
    • 1.5.3 Pediatrics
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Influenza Vaccines Market Size, Estimates and Forecasts
    • 2.1.1 Global Influenza Vaccines Revenue 2015-2026
    • 2.1.2 Global Influenza Vaccines Sales 2015-2026
  • 2.2 Global Influenza Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Influenza Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Influenza Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Influenza Vaccines Competitor Landscape by Players

  • 3.1 Influenza Vaccines Sales by Manufacturers
    • 3.1.1 Influenza Vaccines Sales by Manufacturers (2015-2020)
    • 3.1.2 Influenza Vaccines Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Influenza Vaccines Revenue by Manufacturers
    • 3.2.1 Influenza Vaccines Revenue by Manufacturers (2015-2020)
    • 3.2.2 Influenza Vaccines Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Influenza Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Influenza Vaccines Revenue in 2019
    • 3.2.5 Global Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Influenza Vaccines Price by Manufacturers
  • 3.4 Influenza Vaccines Manufacturing Base Distribution, Product Types
    • 3.4.1 Influenza Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Influenza Vaccines Product Type
    • 3.4.3 Date of International Manufacturers Enter into Influenza Vaccines Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Influenza Vaccines Market Size by Type (2015-2020)
    • 4.1.1 Global Influenza Vaccines Sales by Type (2015-2020)
    • 4.1.2 Global Influenza Vaccines Revenue by Type (2015-2020)
    • 4.1.3 Influenza Vaccines Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Influenza Vaccines Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Influenza Vaccines Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Influenza Vaccines Revenue Forecast by Type (2021-2026)
    • 4.2.3 Influenza Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Influenza Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Influenza Vaccines Market Size by Application (2015-2020)
    • 5.1.1 Global Influenza Vaccines Sales by Application (2015-2020)
    • 5.1.2 Global Influenza Vaccines Revenue by Application (2015-2020)
    • 5.1.3 Influenza Vaccines Price by Application (2015-2020)
  • 5.2 Influenza Vaccines Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Influenza Vaccines Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Influenza Vaccines Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Influenza Vaccines Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Influenza Vaccines by Country
    • 6.1.1 North America Influenza Vaccines Sales by Country
    • 6.1.2 North America Influenza Vaccines Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Influenza Vaccines Market Facts & Figures by Type
  • 6.3 North America Influenza Vaccines Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Influenza Vaccines by Country
    • 7.1.1 Europe Influenza Vaccines Sales by Country
    • 7.1.2 Europe Influenza Vaccines Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Influenza Vaccines Market Facts & Figures by Type
  • 7.3 Europe Influenza Vaccines Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Influenza Vaccines by Region
    • 8.1.1 Asia Pacific Influenza Vaccines Sales by Region
    • 8.1.2 Asia Pacific Influenza Vaccines Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Influenza Vaccines Market Facts & Figures by Type
  • 8.3 Asia Pacific Influenza Vaccines Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Influenza Vaccines by Country
    • 9.1.1 Latin America Influenza Vaccines Sales by Country
    • 9.1.2 Latin America Influenza Vaccines Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Influenza Vaccines Market Facts & Figures by Type
  • 9.3 Central & South America Influenza Vaccines Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Influenza Vaccines by Country
    • 10.1.1 Middle East and Africa Influenza Vaccines Sales by Country
    • 10.1.2 Middle East and Africa Influenza Vaccines Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Influenza Vaccines Market Facts & Figures by Type
  • 10.3 Middle East and Africa Influenza Vaccines Market Facts & Figures by Application

11 Company Profiles

  • 11.1 AstraZeneca
    • 11.1.1 AstraZeneca Corporation Information
    • 11.1.2 AstraZeneca Description and Business Overview
    • 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AstraZeneca Influenza Vaccines Products Offered
    • 11.1.5 AstraZeneca Related Developments
  • 11.2 CSL
    • 11.2.1 CSL Corporation Information
    • 11.2.2 CSL Description and Business Overview
    • 11.2.3 CSL Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 CSL Influenza Vaccines Products Offered
    • 11.2.5 CSL Related Developments
  • 11.3 GlaxoSmithKline
    • 11.3.1 GlaxoSmithKline Corporation Information
    • 11.3.2 GlaxoSmithKline Description and Business Overview
    • 11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 GlaxoSmithKline Influenza Vaccines Products Offered
    • 11.3.5 GlaxoSmithKline Related Developments
  • 11.4 Sanofi
    • 11.4.1 Sanofi Corporation Information
    • 11.4.2 Sanofi Description and Business Overview
    • 11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Sanofi Influenza Vaccines Products Offered
    • 11.4.5 Sanofi Related Developments
  • 11.5 Altimmune
    • 11.5.1 Altimmune Corporation Information
    • 11.5.2 Altimmune Description and Business Overview
    • 11.5.3 Altimmune Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Altimmune Influenza Vaccines Products Offered
    • 11.5.5 Altimmune Related Developments
  • 11.6 BionVax
    • 11.6.1 BionVax Corporation Information
    • 11.6.2 BionVax Description and Business Overview
    • 11.6.3 BionVax Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 BionVax Influenza Vaccines Products Offered
    • 11.6.5 BionVax Related Developments
  • 11.7 FluGen
    • 11.7.1 FluGen Corporation Information
    • 11.7.2 FluGen Description and Business Overview
    • 11.7.3 FluGen Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 FluGen Influenza Vaccines Products Offered
    • 11.7.5 FluGen Related Developments
  • 11.8 FOLIA BIOTECH
    • 11.8.1 FOLIA BIOTECH Corporation Information
    • 11.8.2 FOLIA BIOTECH Description and Business Overview
    • 11.8.3 FOLIA BIOTECH Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 FOLIA BIOTECH Influenza Vaccines Products Offered
    • 11.8.5 FOLIA BIOTECH Related Developments
  • 11.9 Genentech
    • 11.9.1 Genentech Corporation Information
    • 11.9.2 Genentech Description and Business Overview
    • 11.9.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Genentech Influenza Vaccines Products Offered
    • 11.9.5 Genentech Related Developments
  • 11.10 Green Cross
    • 11.10.1 Green Cross Corporation Information
    • 11.10.2 Green Cross Description and Business Overview
    • 11.10.3 Green Cross Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Green Cross Influenza Vaccines Products Offered
    • 11.10.5 Green Cross Related Developments
  • 11.1 AstraZeneca
    • 11.1.1 AstraZeneca Corporation Information
    • 11.1.2 AstraZeneca Description and Business Overview
    • 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AstraZeneca Influenza Vaccines Products Offered
    • 11.1.5 AstraZeneca Related Developments
  • 11.12 Moderna Therapeutics
    • 11.12.1 Moderna Therapeutics Corporation Information
    • 11.12.2 Moderna Therapeutics Description and Business Overview
    • 11.12.3 Moderna Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Moderna Therapeutics Products Offered
    • 11.12.5 Moderna Therapeutics Related Developments
  • 11.13 Novavax
    • 11.13.1 Novavax Corporation Information
    • 11.13.2 Novavax Description and Business Overview
    • 11.13.3 Novavax Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Novavax Products Offered
    • 11.13.5 Novavax Related Developments
  • 11.14 Shijiazhuang Yiling Pharmaceutical
    • 11.14.1 Shijiazhuang Yiling Pharmaceutical Corporation Information
    • 11.14.2 Shijiazhuang Yiling Pharmaceutical Description and Business Overview
    • 11.14.3 Shijiazhuang Yiling Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Shijiazhuang Yiling Pharmaceutical Products Offered
    • 11.14.5 Shijiazhuang Yiling Pharmaceutical Related Developments
  • 11.15 SK Chemicals
    • 11.15.1 SK Chemicals Corporation Information
    • 11.15.2 SK Chemicals Description and Business Overview
    • 11.15.3 SK Chemicals Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 SK Chemicals Products Offered
    • 11.15.5 SK Chemicals Related Developments
  • 11.16 UNM Pharma
    • 11.16.1 UNM Pharma Corporation Information
    • 11.16.2 UNM Pharma Description and Business Overview
    • 11.16.3 UNM Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 UNM Pharma Products Offered
    • 11.16.5 UNM Pharma Related Developments
  • 11.17 Vaccitech
    • 11.17.1 Vaccitech Corporation Information
    • 11.17.2 Vaccitech Description and Business Overview
    • 11.17.3 Vaccitech Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Vaccitech Products Offered
    • 11.17.5 Vaccitech Related Developments
  • 11.18 Vaxart
    • 11.18.1 Vaxart Corporation Information
    • 11.18.2 Vaxart Description and Business Overview
    • 11.18.3 Vaxart Sales, Revenue and Gross Margin (2015-2020)
    • 11.18.4 Vaxart Products Offered
    • 11.18.5 Vaxart Related Developments
  • 11.19 Vaxine Pty
    • 11.19.1 Vaxine Pty Corporation Information
    • 11.19.2 Vaxine Pty Description and Business Overview
    • 11.19.3 Vaxine Pty Sales, Revenue and Gross Margin (2015-2020)
    • 11.19.4 Vaxine Pty Products Offered
    • 11.19.5 Vaxine Pty Related Developments
  • 11.20 Visterra
    • 11.20.1 Visterra Corporation Information
    • 11.20.2 Visterra Description and Business Overview
    • 11.20.3 Visterra Sales, Revenue and Gross Margin (2015-2020)
    • 11.20.4 Visterra Products Offered
    • 11.20.5 Visterra Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Influenza Vaccines Market Estimates and Projections by Region
    • 12.1.1 Global Influenza Vaccines Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Influenza Vaccines Revenue Forecast by Regions 2021-2026
  • 12.2 North America Influenza Vaccines Market Size Forecast (2021-2026)
    • 12.2.1 North America: Influenza Vaccines Sales Forecast (2021-2026)
    • 12.2.2 North America: Influenza Vaccines Revenue Forecast (2021-2026)
    • 12.2.3 North America: Influenza Vaccines Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Influenza Vaccines Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Influenza Vaccines Sales Forecast (2021-2026)
    • 12.3.2 Europe: Influenza Vaccines Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Influenza Vaccines Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Influenza Vaccines Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Influenza Vaccines Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Influenza Vaccines Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Influenza Vaccines Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Influenza Vaccines Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Influenza Vaccines Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Influenza Vaccines Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Influenza Vaccines Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Influenza Vaccines Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Influenza Vaccines Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Influenza Vaccines Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Influenza Vaccines Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Influenza Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Influenza Vaccines Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Influenza Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Influenza Vaccines market is segmented into
    Trivalent Flu Vaccines
    Quadrivalent Flu Vaccines

    Segment by Application, the Influenza Vaccines market is segmented into
    Adults
    Pediatrics

    Regional and Country-level Analysis
    The Influenza Vaccines market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Influenza Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Influenza Vaccines Market Share Analysis
    Influenza Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Influenza Vaccines business, the date to enter into the Influenza Vaccines market, Influenza Vaccines product introduction, recent developments, etc.

    The major vendors covered:
    AstraZeneca
    CSL
    GlaxoSmithKline
    Sanofi
    Altimmune
    BionVax
    FluGen
    FOLIA BIOTECH
    Genentech
    Green Cross
    Medicago
    Moderna Therapeutics
    Novavax
    Shijiazhuang Yiling Pharmaceutical
    SK Chemicals
    UNM Pharma
    Vaccitech
    Vaxart
    Vaxine Pty
    Visterra

    Buy now